BACKGROUND: It is unknown to what extent the gap between need and care for depression among patients with diabetes differs across racial/ethnic groups. We compared, by race/ethnicity, the likelihood of clinical recognition of depression (diagnosis or treatment) of patients who reported depressive symptoms in a well-characterized community-based population with diabetes. DESIGN: We used a survey follow-up study of 20,188 patients with diabetes from Kaiser Permanente Northern California. Analyses were limited to 910 patients who scored 10 or higher on the Patient Health Questionnaire (PHQ-8) which was included in the survey and who had no clinical recognition of depression in the 12 months prior to survey. Clinical recognition of depression was defined by a depression diagnosis, referral to mental health services, or antidepressant medication prescription. RESULTS: Among the 910 patients reporting moderate to severe depressive symptoms on the survey and who had no clinical recognition in the prior year, 12%, 8%, 8%, 14%, and 15% of African American, Asian, Filipino, Latino, and white patients, respectively, were clinically recognized for depression in the subsequent 12 months. After adjusting for sociodemographics, limited English proficiency, and depressive symptom severity, racial/ethnic minorities were less likely to be clinically recognized for depression compared with whites (relative risk: Filipino: 0.30, African American: 0.62). CONCLUSIONS: More work is needed to understand the modifiable patient and provider factors that influence clinical recognition of depression among diabetes patients from different racial/ethnic groups, and the potential impact of low rates of clinical recognition on quality of care.
BACKGROUND: It is unknown to what extent the gap between need and care for depression among patients with diabetes differs across racial/ethnic groups. We compared, by race/ethnicity, the likelihood of clinical recognition of depression (diagnosis or treatment) of patients who reported depressive symptoms in a well-characterized community-based population with diabetes. DESIGN: We used a survey follow-up study of 20,188 patients with diabetes from Kaiser Permanente Northern California. Analyses were limited to 910 patients who scored 10 or higher on the Patient Health Questionnaire (PHQ-8) which was included in the survey and who had no clinical recognition of depression in the 12 months prior to survey. Clinical recognition of depression was defined by a depression diagnosis, referral to mental health services, or antidepressant medication prescription. RESULTS: Among the 910 patients reporting moderate to severe depressive symptoms on the survey and who had no clinical recognition in the prior year, 12%, 8%, 8%, 14%, and 15% of African American, Asian, Filipino, Latino, and white patients, respectively, were clinically recognized for depression in the subsequent 12 months. After adjusting for sociodemographics, limited English proficiency, and depressive symptom severity, racial/ethnic minorities were less likely to be clinically recognized for depression compared with whites (relative risk: Filipino: 0.30, African American: 0.62). CONCLUSIONS: More work is needed to understand the modifiable patient and provider factors that influence clinical recognition of depression among diabetespatients from different racial/ethnic groups, and the potential impact of low rates of clinical recognition on quality of care.
Authors: Paul E Greenberg; Ronald C Kessler; Howard G Birnbaum; Stephanie A Leong; Sarah W Lowe; Patricia A Berglund; Patricia K Corey-Lisle Journal: J Clin Psychiatry Date: 2003-12 Impact factor: 4.384
Authors: Lisa A Cooper; Junius J Gonzales; Joseph J Gallo; Kathryn M Rost; Lisa S Meredith; Lisa V Rubenstein; Nae-Yuh Wang; Daniel E Ford Journal: Med Care Date: 2003-04 Impact factor: 2.983
Authors: Wayne Katon; Michael von Korff; Paul Ciechanowski; Joan Russo; Elizabeth Lin; Gregory Simon; Evette Ludman; Edward Walker; Terry Bush; Bessie Young Journal: Diabetes Care Date: 2004-04 Impact factor: 19.112
Authors: Alka M Kanaya; Nancy Adler; Howard H Moffet; Jennifer Liu; Dean Schillinger; Alyce Adams; Ameena T Ahmed; Andrew J Karter Journal: Diabetes Care Date: 2011-02-24 Impact factor: 19.112
Authors: Neda Laiteerapong; Andrew J Karter; Jennifer Y Liu; Howard H Moffet; Rebecca Sudore; Dean Schillinger; Priya M John; Elbert S Huang Journal: Diabetes Care Date: 2011-06-02 Impact factor: 19.112
Authors: Arne Beck; Arthur J Davidson; Stanley Xu; M Josh Durfee; Carlos Irwin A Oronce; John F Steiner; Edward Havranek Journal: J Urban Health Date: 2017-12 Impact factor: 3.671
Authors: Neda Laiteerapong; Andrew J Karter; Priya M John; Dean Schillinger; Howard H Moffet; Jennifer Y Liu; Nancy Adler; Marshall H Chin; Elbert S Huang Journal: J Am Geriatr Soc Date: 2013-06-24 Impact factor: 5.562
Authors: Andrew J Karter; Neda Laiteerapong; Marshall H Chin; Howard H Moffet; Melissa M Parker; Rebecca Sudore; Alyce S Adams; Dean Schillinger; Nancy S Adler; Rachel A Whitmer; John D Piette; Elbert S Huang Journal: J Aging Health Date: 2015-02-05
Authors: Amy M Bauer; Melissa M Parker; Dean Schillinger; Wayne Katon; Nancy Adler; Alyce S Adams; Howard H Moffet; Andrew J Karter Journal: J Gen Intern Med Date: 2014-08 Impact factor: 5.128
Authors: Amy M Bauer; Melissa M Parker; Howard H Moffet; Dean Schillinger; Nancy E Adler; Alyce S Adams; Julie A Schmittdiel; Wayne J Katon; Andrew J Karter Journal: Patient Prefer Adherence Date: 2017-03-24 Impact factor: 2.711